Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 2

Status

Recruiting 4Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 15OTHER 6

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

NET 2Genitourinary 2Endocrine 2Other solid neoplasm 1Gastrointestinal 1

Conditions

Solid Tumors 1Prostatic Neoplasms 1Prostate Cancer Metastatic 1Neuroendocrine Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoma, Adenoid Cystic 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Interventional × Lutetium × Clear all
NCT07150546 2026-03-02

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Emory University

Phase 1 Recruiting
15 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT06320067 2025-09-26

STAMPEDE2

University College, London

Phase 3 Recruiting
3,360 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT06878664 2025-09-02

RIALTO

Grupo Espanol de Tumores Neuroendocrinos

Phase 3 Recruiting
166 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT06199453 2025-02-10

LuRM_ACC/2023

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Withdrawn

Carcinoma, Adenoid Cystic

NCT06449781 2025-02-10

PSMA-ADJUVO

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT06553846 2024-08-14

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Fudan University

Phase 1 Not yet recruiting
50 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡